Abstract
Objective
Islet α cells input is essential for insulin secretion from β cells. The present study aims to investigate the association between 25-hydroxyvitamin D [25(OH)D] and islet function homeostasis in type-2 diabetes (T2D) patients.
Methods
A total of 4670 T2D patients from seven communities in Shanghai, China were enrolled. The anthropometric indices, biochemical parameters, serum 25(OH)D, and islet function [including C-peptide (C-p) and glucagon] were measured.
Results
The fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), glucagon, and C-p levels exhibited a significantly decreasing trend in T2D patients as the 25(OH)D levels increased. Next, the population was divided into two groups: abdominal obesity and non-abdominal obesity groups. After adjustment, the 25(OH)D level was found to be associated with HbA1c, glucagon, and homeostasis model assessment of β (HOMA-β) in the non-abdominal obesity group. There was a significant relationship between 25(OH)D and HbA1c, glucagon, HOMA-IR, baseline insulin or C-p in the abdominal obesity group. In the abdominal obesity group, the ordinary least squares (OLS) regression and quantile regression revealed that 25(OH) D was obviously associated with glucagon and fasting C-p levels. In the abdominal obesity group, the moderate analysis revealed a significant interaction effect of 25(OH)D and glucagon on C-p (P=0.0124). Furthermore, the conditional indirect effect of 25(OH)D on the glucagon/C-p ratio was significantly lower at 1 standard deviation (SD) below the mean (P=0.0002), and lower at the mean of the course of diabetes (P=0.0007).
Conclusion
25(OH)D was found to be negatively correlated to glucagon and C-p in T2D patients with abdominal obesity. The 25(OH)D influenced C-p in part by influencing glucagon. The effect of 25(OH)D on the glucagon/C-p ratio in T2D patients with abdominal obesity, in terms of islet homeostasis, is influenced by the course of diabetes.
Similar content being viewed by others
References
Svendsen B, Larsen O, Gabe MBN, et al. Insulin Secretion Depends on Intra-islet Glucagon Signaling. Cell Rep, 2018,25(5):1127–1134
Ackermann AM, Wang Z, Schug J, et al. Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes. Mol Metab, 2016,5(3):233–244
Capozzi ME, Wait JB, Koech J, et al. Glucagon lowers glycemia when beta-cells are active. JCI Insight, 2019,5(16):e129954
Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr, 2008,87(4):1080s–1086s
Mathieu C, Gysemans C, Giulietti A, et al. Vitamin D and diabetes. Diabetologia, 2005,48(7):1247–1257
Sandler S, Buschard K, Bendtzen K. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro. Immunol Lett, 1994,41(1):73–77
Norman AW, Frankel JB, Heldt AM, et al. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science, 1980,209(4458):823–825
de Souza Santos R, Vianna LM. Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats. Clin Chim Acta, 2005,358(1–2):146–150
Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr, 1994,59(5):1083–1087
Elseweidy MM, Amin RS, Atteia HH, et al. Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylation in diabetic rats. Biomed Pharmacother, 2017,85:155–159
Viloria K, Hewison M, Hodson DJ. Vitamin D binding protein/GC-globulin: a novel regulator of alpha cell function and glucagon secretion. J Physiol, 2022,600(5):1119–1133
Wan H, Wang Y, Xiang Q, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol, 2020,19(1):118
Wang Y, Weng P, Wan H, et al. Economic Status Moderates the Association Between Early-Life Famine Exposure and Hyperuricemia in Adulthood. J Clin Endocrinol Metab, 2020,105(11):dgaa523
Chen Y, Cheng J, Chen Y, et al. Association between serum vitamin D and uric acid in the eastern Chinese population: a population-based cross-sectional study. BMC Endocr Disord, 2020,20(1):79
Li Q, Lu M, Wang NJ, et al. Relationship between Free Thyroxine and Islet Beta-cell Function in Euthyroid Subjects. Curr Med Sci, 2020,40(1):69–77
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. Jama, 2013,310(9):948–959
Brissova M, Fowler MJ, Nicholson WE, et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem, 2005,53(9):1087–1097
Zhao H, Zheng C, Zhang M, et al. The relationship between vitamin D status and islet function in patients with type 2 diabetes mellitus. BMC Endocr Disord, 2021,21(1):203
Heaney RP. Toward a physiological referent for the vitamin D requirement. J Endocrinol Invest, 2014,37(11):1127–1130
Ekwaru JP, Zwicker JD, Holick MF, et al. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One, 2014,9(11):e111265
Alkhatatbeh MJ, Abdul-Razzak KK. Association between serum 25-hydroxyvitamin D, hemoglobin A1c and fasting blood glucose levels in adults with diabetes mellitus. Biomed Rep, 2018,9(6):523–530
Mirhosseini N, Vatanparast H, Mazidi M, et al. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol Metab, 2017,102(9):3097–3110
Zoppini G, Galletti A, Targher G, et al. Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients. PLoS One, 2013,8(12):e82733
Wang N, Wang C, Chen X, et al. Vitamin D, prediabetes and type 2 diabetes: bidirectional Mendelian randomization analysis. Eur J Nutr, 2020,59(4):1379–1388
Pittas AG, Dawson-Hughes B, Sheehan P, et al. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med, 2019,381(6):520–530
Ryu OH, Lee S, Yu J, et al. A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea. Endocr J, 2014,61(2):167–176
Bouillon R, Manousaki D, Rosen C, et al. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol, 2022,18(2):96–110
Al-Sofiani ME, Jammah A, Racz M, et al. Effect of Vitamin D Supplementation on Glucose Control and Inflammatory Response in Type II Diabetes: A Double Blind, Randomized Clinical Trial. Int J Endocrinol Metab, 2015,13(1):e22604
Jafari T, Faghihimani E, Feizi A, et al. Effects of vitamin D-fortified low fat yogurt on glycemic status, anthropometric indexes, inflammation, and bone turnover in diabetic postmenopausal women: A randomised controlled clinical trial. Clin Nutr, 2016,35(1):67–76
Barrea L, Frias-Toral E, Pugliese G, et al. Vitamin D in obesity and obesity-related diseases: an overview. Minerva Endocrinol (Torino), 2021,46(2):177–192
Kjalarsdottir L, Tersey SA, Vishwanath M, et al. 1,25-Dihydroxyvitamin D(3) enhances glucose-stimulated insulin secretion in mouse and human islets: a role for transcriptional regulation of voltage-gated calcium channels by the vitamin D receptor. J Steroid Biochem Mol Biol, 2019,185:17–26
Takiishi T, Ding L, Baeke F, et al. Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long term. Diabetes, 2014,63(6):2026–2036
El K, Capozzi ME, Campbell JE. Repositioning the Alpha Cell in Postprandial Metabolism. Endocrinology, 2020,161(11):bqaa169
Zhu L, Dattaroy D, Pham J, et al. Intra-islet glucagon signaling is critical for maintaining glucose homeostasis. JCI Insight, 2019,5(10):e127994
Rodriguez-Diaz R, Tamayo A, Hara M, et al. The Local Paracrine Actions of the Pancreatic alpha-Cell. Diabetes, 2020,69(4):550–558
Viloria K, Nasteska D, Briant LJB, et al. Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion. Cell Rep, 2020,31(11):107761
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare that there are no conflicts of interest or financial interests associated with the manuscript.
Additional information
This study was supported by the National Natural Science Foundation of China (No. 82120108008, No. 91857117), the Project of Biobank (No. YBKA201909) from Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, and a grant from Shanghai Jiaotong University School of Medicine (No. 19XJ11007).
Rights and permissions
About this article
Cite this article
Li, Q., Zhang, W., Han, B. et al. 25-Hydroxyvitamin D Is Associated with Islet Homeostasis in Type-2 Diabetic Patients with Abdominal Obesity. CURR MED SCI 43, 919–926 (2023). https://doi.org/10.1007/s11596-023-2780-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-023-2780-z